Role of three ELISA tests using promastigote homogenates of leishmania braziliensis, l. amazonensis and l. guyanensis in the diagnosis of tegumentary leishmaniasis;El rol de tres pruebas de elisa con antigenos de promastigotes de leishmania braziliensis, l. amazonensis y l. guyanensis en el diagnostico de leishmaniasis tegumentaria

Medicina

Volumn 71, Issue 5, 2011, Pages 420-428

  Gil, Jose F ^a,b,c   Hoyos, Carlos L ^a   Cimino, Ruben O ^a,b   Krolewiecki, Alejandro J ^a,c   Quiroga, Ines L ^b   Cajal, Silvana P ^a   Juarez, Marisa ^a   Bustos, Maria F Garcia ^c   Mora, Maria C ^c   Marco, Jorge D ^c   Nasser, Julio R ^a,b  

^a Instituto de Investigaciones en Enfermedades Tropicales   (Argentina)

^b Facultad de Ciencias Naturales   (Argentina)

^c UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

Diagnostic; ELISA; Leishmaniasis

Indexed keywords

ARTICLE; BOOTSTRAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEISHMANIA BRAZILIENSIS; NONHUMAN; PREDICTIVE VALUE; PROMASTIGOTE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SKIN LEISHMANIASIS; TRYPANOSOMA CRUZI;

ANALYSIS OF VARIANCE; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CONFIDENCE INTERVALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA GUYANENSIS; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, MUCOCUTANEOUS; PROTOZOAN PROTEINS; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA CRUZI;

EID: 84857526574     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Grimaldi G, Jr., Tesh RB. Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev 1993; 6: 230-50.
2. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis 2007; 7: 581-96.
3. Salomon OD, Orellano PW, Quintana MG, et al. Transmisión de la leishmaniasis tegumentaria en Argentina. Medicina (B Aires) 2006; 66: 211-9.
4. Krolewiecki A, Cajal P, Juárez M, et al. Análisis clínico epidemiológico de la Leishmaniasis Tegumentaria Americana en Orán, Salta. III Simposio Internacional de Epidemiología y II Encuentro Nacional de Epidemiólogos de Campo. Buenos Aires, Argentina 2007; Abstract N° 16.
5. Gil J, Cajal S, Acosta N, et al. Descripción epidemiológica de la leishmaniasis en el norte de la provincia de Salta. III Congreso Latinoamericano de Zoonosis VI Congreso Argentino de Zoonosis. Buenos Aires, Argentina 2008; Abstract N° 20.
6. Hashiguchi Y, Gomez E, Uezato H, et al. Comparison of diffuse (DCL) and disseminated (DSCL) cutaneous Leishmaniasis: an overview of cases observed in Ecuador, and a brief comment. Hashiguchi Y, ed. Studies on New World Leishmaniasis and its Transmission, with Particular Reference to Ecuador, Peru, Argentina and Pakistan. Research Report Series No. 8. Kochi, Japan: Kyowa Printing, 2008.
7. Salomón OD, Sosa Estani S, Rossi GC, Spinelli GR. Presencia de Lutzomyia longipalpis y situación de la leishmaniosis visceral en Argentina. Medicina (B Aires) 2001; 61: 174-8.
8. Krolewiecki AJ, Romero HD, Cajal SP, et al. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis. Am J Trop Med Hyg 2007; 77: 640-6.
9. Marco JD, Uezato H, Mimori T, et al. Are cytochrome B gene sequencing and polymorphism-specific polymerase chain reaction as reliable as multilocus enzyme electrophoresis for identifying Leishmania spp. from Argentina? Am J Trop Med Hyg 2006; 75: 256-60.
10. Marco JD, Barroso PA, Calvopina M, et al. Species assignation of Leishmania from human and canine American tegumentary leishmaniasis cases by multilocus enzyme electrophoresis in North Argentina. Am J Trop Med Hyg 2005; 72: 606-11.
11. Frank FM, Fernandez MM, Taranto NJ, et al. Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved. Parasitology 2003; 126: 31-9.
12. Barrio A, García Bustos M, Mora M, et al. Identification by PS-PCR of Leishmania species and its correlation with clinical, epidemiologic, and therapeutic characteristics in Salta, Argentina. Revista Argentina de Salud Pública 2009; 1: 30-3.
13. Barrio A, Mora MC, Ramos F, Moreno S, Samson R, Basombrio MA. Use of kDNA-based polymerase chain reaction as a sensitive and differentially diagnostic method of American Tegumentary Leishmaniasis in disease-endemic areas of northern Argentina. Am J Trop Med Hyg 2007; 77: 636-9.
14. Reithinger R, Dujardin JC. Molecular diagnosis of leishmaniasis: current status and future applications. J Clin Microbiol 2007; 45: 21-5.
15. Zeyrek FY, Korkmaz M, Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clin Vaccine Immunol 2007; 14: 1409-15.
16. Ferreira MP, Roselino AM, Nascimento MM, Aires JM, Figueiredo JF. Sensitivity of an immunoenzymatic test for detection of anti-L. brasiliensis antibodies compared to other tests used for the diagnosis of American cutaneous leishmaniasis. Rev Inst Med Trop Sao Paulo 2006; 48:215-7.
17. Taranto NJ, Cajal SP, De Marzi MC, et al. Clinical status and parasitic infection in a Wichi Aboriginal community in Salta, Argentina. Trans R Soc Trop Med Hyg 2003; 97: 554-8.
18. Tapia FJ, Castes M. Inmunología de la Leishmaniasis Tegumentaria Americana. En: www.biomedicina.org.ve/publicaciones, 1998; consultado el 15-01-2011.
19. Pereyra V, Gil J, Cimino R, et al. Serología de pacientes con Leishmaniasis Tegumentaria Americana (LTA) tratados con dihidrato de Azitromicina (AZTM) y Antimoniato de N-Metil-glucamina (Sbv) que evidenciaron cura clínica. XXII Reunión Anual de la Sociedad Argentina de Protozología. Chascomús, Buenos Aires, Argentina 1998; Abstract N° IN-16.
20. Marco J, Korenaga M, Barroso P, et al. Immunoglobulins isotopes and IgG subclasses as molecular markers of efficacy of pentavalent antimonials treatment of American tegumentary leishmaniasis. 63rd Annual Meeting of the Japanese Society of Parasitology - Western region Kochi, Japan 2007; Abstract N° 22.
21. Junqueira Pedras M, Orsini M, Castro M, Passos VM, Rabello A. Antibody subclass profile against Leishmania braziliensis and Leishmania amazonensis in the diagnosis and follow-up of mucosal leishmaniasis. Diagn Microbiol Infect Dis 2003; 47: 477-85.
22. Fagundes A, Marzochi MC, Fernandes O, et al. First encounter of subclinical human Leishmania (Viannia) infection in State of Rio Grande do Sul, Brazil. Mem Inst Oswaldo Cruz 2007; 102: 1003-5.
23. Sosa-Estani S, Segura EL, Salomon OD, et al. Tegumentary leishmaniasis in Northern Argentina: distribution of infection and disease, in three municipalities of Salta, 1990-1992. Rev Soc Bras Med Trop 2000; 33: 573-82.
24. Salomon OD, Sosa Estani S, Canini L, Córdoba Lanús E. Leishmaniasis tegumentaria en un área con niveles epidémicos de transmisión, Salta, Argentina 1998. Medicina (B Aires) 2001; 61: 284-90.
25. Garcez LM, Silveira FT, el Harith A, Lainson R, Shaw JJ. Experimental cutaneous leishmaniasis. IV. The humoral response of Cebus apella (Primates: Cebidae) to infections of Leishmania (Leishmania) amazonensis, L. (Viannia) lainsoni and L. (V.) braziliensis using the direct agglutination test. Acta Trop 1997; 68: 65-76.
26. Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, et al. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Acta Trop 2005; 93: 49-56.
27. Ribeiro FC, Schubach AdO, Mouta-Confort E, Schubach TMP, Madeira MdF, Marzochi MCA. Use of ELISA employing Leishmania (Viannia) braziliensis and Leishmania (Leishmania) chagasi antigens for the detection of IgG and IgG1 and IgG2 subclasses in the diagnosis of American tegumentary leishmaniasis in dogs. Vet Parasitology 2007; 148: 200-6.
28. Vidigal C de P, Marcussi VM, Marcussi LM, et al. Enzyme immunoassay using Leishmania (Viannia) braziliensis antigens for laboratorial diagnosis of American cutaneous leishmaniasis. Acta Trop 2008; 107: 208-12.
29. Caballero ZC, Sousa OE, Marques WP, Saez-Alquezar A, Umezawa ES. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp. Clin Vaccine Immunol 2007; 14: 1045-9.
30. Evans D. Handbook on Isolation, Characterization, and Cryopreservation of Leishmania. Editor: WHO. Geneva, 1989; pp. 1-45.
31. Bradford M. A rapid and sensitive method for the quantitative analysis of microgram quantities of protein utilizing the principle of protein dye binding. An Biochem 1976: 248-54.
32. Cimino R, Monje Rumi M, Ragone P, et al. Immunoenzimatic evaluation of the recombinant TSSA-II protein of Trypanosoma cruzi in dogs and human sera: A tool for epidemiologic studies. Parasitology 2011; 26:1-8.
33. Krolewiecki AJ, Ramanathan R, Fink V, et al. Improved diagnosis of Strongyloides stercoralis using recombinant antigen-based serologies in a community-wide study in northern Argentina. Clin Vaccine Immunol 2010; 17: 1624-30.
34. Gil J, Cimino R, López Quiroga I, et al. Reactividad del antígeno GST-SAPA de Trypanosoma cruzi frente a sueros de pacientes con enfermedad de Chagas y Leishmania. Medicina (B Aires) 2011; 71: 113-19.
35. Taranto NJ. Patologías endémicas. En: Rubinski RO, Voyer LE y Cambiano CT, eds. Pediatría. Buenos Aires. Ediciones Journal 2003. p 530-41.
36. Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 2010; 8: 419-33.
37. Yoneyama KA, de Peder LD, Lonardoni MV, Silveira TG. Diagnosis of American cutaneous leishmaniasis by enzyme immunoassay in patients from Northern Parana State, Brazil. Braz J Infect Dis 2007; 11: 360-4.
38. Guimarães MC, Celeste BJ, Franco EL. Evaluation of dot enzyme-linked immunosorbent assay for mucocutaneous leishmaniasis and comparison with microplate enzyme immunoassay. J Clin Microbiol 1986; 24: 364-7.
39. Zeyrek FY, Korkmaz M, Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL is highly endemic. Clin Vaccine Immunol 2007; 14: 1409-15.
40. Ryan JR, Smithyman AM, Rajasekariah GH, Hochberg L, Stiteler JM, Martin SK. Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis. J Clin Microbiol 2002; 40: 1037-43.
41. Convit J, Pinardi ME. Applying the indirect immunofluorescency test to the study of American cutaneous leishmaniasis. Dermatol Int 1969; 8: 17-20.
42. Menzel S, Bienzle U. Antibody responses in patients with cutaneous leishmaniasis of the Old World. Tropenmed Parasitol 1978; 29: 194-7.
43. Walton BC. Evaluation of chemotherapy of American leishmaniasis by the indirect fluorescent antibody test. Am J Trop Med Hyg 1980; 29: 747-52.
44. Mendonca SC, Souza WJ, Nunes MP, Marzochi MC, Coutinho SG. Indirect immunofluorescence test in New World leishmaniasis: serological and clinical relationship. Mem Inst Oswaldo Cruz 1988; 83: 347-55.
45. Gomes Casavechia M, Gomes Verzignassi Silveira T, Teodoro U, Janeiro V, Udo M, Valdrinez Campana Lonardoni M. Variables associated with the post-treatment healing of lesions in patients with American cutaneous leishmaniasis in Paraná State, Brazil. Brazilian Journal of Pharmaceutical Sciences 2009; 45: 841-7.
46. Amorim AG, Carrington M, Miles MA, Barker DC, de Almeida ML. Identification of the C-terminal region of 70 kDa heat shock protein from Leishmania (Viannia) braziliensis as a target for the humoral immune response. Cell Stress Chaperones 1996; 1: 177-87.
47. Vexenat Ade C, Santana JM, Teixeira AR. Cross-reactivity of antibodies in human infections by the kinetoplastid protozoa Trypanosoma cruzi, Leishmania chagasi and Leishmania (viannia) braziliensis. Rev Inst Med Trop Sao Paulo 1996; 38: 177-85.
48. Ramirez JL, Guevara P. Persistent infections by Leishmania (Viannia) braziliensis. Mem Inst Oswaldo Cruz 1997; 92: 333-8.
49. Schubach A, Marzochi MC, Cuzzi-Maya T, et al. Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure. Am J Trop Med Hyg 1998; 58: 824-7.
50. Gil JF, Nasser JR, Cajal SP, et al. Urban transmission of American cutaneous leishmaniasis in Argentina: spatial analysis study. Am J Trop Med Hyg 2010; 82: 433-40.
51. Hoyos C, Cajal S, Acosta N, et al. Epidemiología de la Leishmaniasis Tegumentaria Americana en Hipólito Yrigoyen, Dpto. Orán. Salta. XXIV Reunión Científica Anual Sociedad Argentina de Protozoología. Ascochinga, Córdoba, Argentina 2010; Abstract N° EyV19.
52. Chiaramonte MG, Zwirner NW, Caropresi SL, Heredia V, Taranto NJ, Malchiodi EL. Estudio de casos de leishmaniasis en la provincia de Salta. Evidencias de infección mixta por Trypanosoma cruzi y Leishmania spp. Medicina (B Aires) 1996; 56: 259-68.